A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
Police are appealing for help in tracing a family of six who are feared to be travelling to Syria.
A "truly despicable" thief stole from a woman while she suffered a violent epileptic seizure.
A senior health official has called for vitamin supplements for children amid warnings over a rickets 'epidemic'.